Clinical trial for Hand Osteoarthritis
Official title Multiprofen-CC to Reduce Pain in Hand Arthritis
ClinicalTrials.gov ID: NCT06966206
What this study is testing
What is Multiprofen-CC™ plus standard treatment?
Multiprofen-CC™ plus standard treatment is an investigational medicine, applied to the skin, being studied as a potential treatment for hand osteoarthritis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether Multiprofen-CC cream can lower pain in adults with hand osteoarthritis. It also looks at hand function, opioid use, and overall improvement.
- Who it's for
- You may be able to join if you are an adult with hand osteoarthritis and can apply cream to your hands.
- What's involved
- You will use 1 gram of Multiprofen-CC cream and a pretend cream, each three times a day for 2 weeks. You will apply the creams in a random order and report any symptoms.
- Time commitment
- The study lasts 6 weeks and includes visits before starting, after 2 weeks, and after 6 weeks.
- Phase 3: a large, late-stage study
You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (18+)
- Have been diagnosed with hand osteoarthritis according to American College of Rheumatology criteria
- Experience pain and/or loss of function in one or both hands that interferes with daily life
- Provide informed consent
You likely can't join if
- Unable to consent
- Unable or unwilling to follow study protocol
- Known allergy or contraindication to any of the study drugs or their ingredients
- Have open wounds/cuts and/or skin conditions on the hand area
- Pregnant or breastfeeding
- History of impaired kidney or liver function
See the full eligibility criteria
- Adults (18+)
- Have been diagnosed with hand osteoarthritis according to American College of Rheumatology criteria
- Experience pain and/or loss of function in one or both hands that interferes with daily life
- Provide informed consent
- Unable to consent
- Unable or unwilling to follow study protocol
- Known allergy or contraindication to any of the study drugs or their ingredients
- Have open wounds/cuts and/or skin conditions on the hand area
- Pregnant or breastfeeding
- History of impaired kidney or liver function
- Rheumatoid or other inflammatory arthropathy
- Hand surgery within the past 6 months or planned within the study period.
- Use daily opioids (other than short acting codeine) for a chronic pain condition other than hand arthritis
The study team makes the final eligibility decision.
Where it is enrolling
- Hamilton, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hamilton, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.